Evidence map›Paper›PMID 34361089›Full record

ReviewInternational journal of molecular sciences2021

Signaling Pathways Regulated by UBR Box-Containing E3 Ligases.

Jung Gi Kim, Ho-Chul Shin, Taewook Seo, Laxman Nawale, Goeun Han, Bo Yeon Kim, Seung Jun Kim, Hyunjoo Cha-Molstad

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jung Gi KimAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 28116, Korea.
Ho-Chul ShinDisease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea.ORCID 0000-0001-7878-0367
Taewook SeoAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 28116, Korea.
Laxman NawaleAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 28116, Korea.
Goeun HanAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 28116, Korea.
Bo Yeon KimAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 28116, Korea.
Seung Jun KimDepartment of Biomolecular Science, KRIBB School, University of Science and Technology, Daejeon 34113, Korea.
Hyunjoo Cha-MolstadAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 28116, Korea.
Korea Research Institute of Bioscience and Biotechnology · KR

Funding

Korea Research Institute of Bioscience and Biotechnology 1711134091National Research Foundation of Korea 2020R1A2C1010512National Research Foundation of Korea 2021R1A2C3004965
6 · The paper itself

Abstract

UBR box E3 ligases, also called N-recognins, are integral components of the N-degron pathway. Representative N-recognins include UBR1, UBR2, UBR4, and UBR5, and they bind destabilizing N-terminal residues, termed N-degrons. Understanding the molecular bases of their substrate recognition and the biological impact of the clearance of their substrates on cellular signaling pathways can provide valuable insights into the regulation of these pathways. This review provides an overview of the current knowledge of the binding mechanism of UBR box N-recognin/N-degron interactions and their roles in signaling pathways linked to G-protein-coupled receptors, apoptosis, mitochondrial quality control, inflammation, and DNA damage. The targeting of these UBR box N-recognins can provide potential therapies to treat diseases such as cancer and neurodegenerative diseases.

Indexed as

ApoptosisDNA DamageSignal TransductionAnimalsHumansInflammationReceptors, G-Protein-CoupledUbiquitin-Protein LigasesReceptors, G-Protein-CoupledUbiquitin-Protein LigasesapoptosisArg/N-degron pathwayDNA damageG-protein signalinginflammatory responsemitochondrial quality controlN-degronN-recogninUBR Box E3 ligases

Identifiers

PMID34361089
PMCPMC8346999
OpenAlexW3190164882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.